Related references
Note: Only part of the references are listed.Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions
Christopher A. Lipinski
ADVANCED DRUG DELIVERY REVIEWS (2016)
Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs
Adrian Whitty et al.
DRUG DISCOVERY TODAY (2016)
Cell-Permeable Cyclic Peptides from Synthetic Libraries Inspired by Natural Products
William M. Hewitt et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
Bradley Croy Doak et al.
CHEMISTRY & BIOLOGY (2014)
The Emergence of Cyclic Peptides: The Potential of Bioengineered Peptide Drugs
Parashar Thapa et al.
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2014)
Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?
Fabrizio Giordanetto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Physicochemical Descriptors of Aromatic Character and Their Use in Drug Discovery
Timothy J. Ritchie et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Form and Function in Cyclic Peptide Natural Products: A Pharmacokinetic Perspective
Andrew T. Bockus et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Cyclic Peptides as Therapeutic Agents and Biochemical Tools
Sang Hoon Joo
BIOMOLECULES & THERAPEUTICS (2012)
Therapeutic peptides FOREWORD
Fernando Albericio et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Antibacterial agents based on the cyclic D,L-α-peptide architecture
S Fernandez-Lopez et al.
NATURE (2001)
Drug-like properties and the causes of poor solubility and poor permeability
CA Lipinski
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2000)
Share Paper
